Modified H7 hemagglutinin glycoprotein of the Influenza A/Shanghai/2/2013 H7 sequence

摘要

The present invention is directed to a sequence modification of the H7 hemagglutinin glycoprotein of the Influenza A/Shanghai/2/2013 H7 sequence together with vaccines derived therefrom. In addition, the invention further comprises method for improving the efficacy of vaccine antigens by modifying T cell epitopes.